Transcription factor CCAAT/enhancer binding protein alpha up-regulates microRNA let-7a-1 in lung cancer cells by

Yani Lin1, Jian Zhao2, Xiaoyan Hu1

  • 1Department of Biochemistry and Molecular Biology, School of Medicine, Shandong University, Jinan, 250012 People's Republic of China.

Abstract

Insights

CCAAT/enhancer binding protein α (C/EBPα) down-regulation in lung cancer cells leads to decreased microRNA let-7a-1 expression. This study identifies let-7a-1 as a direct transcriptional target of C/EBPα in lung cancer.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Gene Regulation

Background:

  • CCAAT/enhancer binding protein α (C/EBPα) and microRNA (miRNA) let-7a-1 are known tumor suppressors in various cancers, including lung cancer.
  • Dysregulation of C/EBPα and let-7a-1 is observed in lung cancer cells.

Purpose of the Study:

  • To investigate if let-7a-1 is a novel target of C/EBPα in lung cancer cells.
  • To elucidate the regulatory relationship between C/EBPα and let-7a-1 in lung cancer.

Main Methods:

  • Bioinformatic analysis of the let-7a-1 promoter for C/EBP binding sites.
  • Quantitative real-time PCR and Western blotting to assess gene and protein expression.
  • Dual-luciferase reporter gene assays to confirm transcriptional regulation.
  • Electrophoretic mobility shift assays and chromatin immunoprecipitation to validate C/EBPα binding to the let-7a-1 promoter.

Main Results:

  • C/EBPα and let-7a-1 were found to be downregulated in human lung cancer cell lines (A549, H1299).
  • C/EBPα was shown to increase let-7a-1 expression at the transcriptional level.
  • Four C/EBP binding elements in the let-7a-1 promoter were identified and confirmed to mediate C/EBPα's regulatory effect.

Conclusions:

  • Decreased levels of C/EBPα contribute to the downregulation of miRNA let-7a-1 in lung cancer cells.
  • let-7a-1 is a direct transcriptional target of C/EBPα, and this interaction is disrupted in lung cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
8.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K